BioScrip Company Profile (NASDAQ:BIOS)

About BioScrip

BioScrip logoBioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BIOS
  • CUSIP: 09069N10
Key Metrics:
  • Previous Close: $2.92
  • 50 Day Moving Average: $2.736
  • 200 Day Moving Average: $2.570
  • 52-Week Range: $1.19 - $3.09
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -36.13
  • P/E Growth: -0.840
  • Market Cap: $331.96M
  • Outstanding Shares: 113,880,000
  • Beta: 0.68
Profitability:
  • Net Margins: -5.63%
  • Return on Equity: -609.04%
  • Return on Assets: -6.27%
Debt:
  • Debt-to-Equity Ratio: -21.59%
  • Current Ratio: 1.96%
  • Quick Ratio: 1.64%
Additional Links:
Companies Related to BioScrip:

Analyst Ratings

Consensus Ratings for BioScrip (NASDAQ:BIOS) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for BioScrip (NASDAQ:BIOS)
Show:
DateFirmActionRatingPrice TargetDetails
3/5/2016StephensReiterated RatingBuyView Rating Details
8/12/2015Dougherty & CoLower Price TargetBuy$7.00 -> $4.00View Rating Details
8/11/2015SunTrust Banks Inc.DowngradeBuy -> Neutral$5.00 -> $2.00View Rating Details
5/23/2015Barrington ResearchReiterated RatingOutperform$7.00 -> $6.00View Rating Details
5/8/2015Jefferies GroupLower Price TargetBuy$8.00 -> $6.50View Rating Details
4/9/2015Craig HallumInitiated CoverageBuy$7.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for BioScrip (NASDAQ:BIOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/8/2016Q216($0.09)($0.14)$229.58 million$232.50 millionViewListenView Earnings Details
5/5/2016Q1($0.12)($0.17)$232.38 million$238.50 millionViewListenView Earnings Details
3/2/2016Q4($0.08)($0.13)$238.30 million$243.75 millionViewListenView Earnings Details
11/4/2015Q315($0.10)($0.38)$229.89 million$247.20 millionViewListenView Earnings Details
8/10/2015Q215($0.11)($3.60)$269.38 million$262.40 millionViewListenView Earnings Details
5/7/2015Q115($0.04)($0.17)$259.60 million$261.70 millionViewListenView Earnings Details
3/2/2015Q414$0.01($0.69)$259.62 million$253.70 millionViewListenView Earnings Details
11/5/2014Q314$0.02($0.42)$240.08 million$244.00 millionViewListenView Earnings Details
8/6/2014Q214($0.02)($0.01)$233.70 million$247.10 millionViewListenView Earnings Details
5/8/2014Q114($0.03)($0.13)$222.65 million$239.60 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$237.58 million$243.50 millionViewListenView Earnings Details
8/7/2013Q2 2013$0.04$0.13$206.47 million$190.73 millionViewListenView Earnings Details
5/8/2013Q1 2013$0.02$0.04$189.36 million$199.07 millionViewListenView Earnings Details
3/11/2013Q4 2012$0.01$0.04$173.87 million$180.70 millionViewListenView Earnings Details
11/7/2012Q312($0.01)($0.01)$159.86 million$170.36 millionViewN/AView Earnings Details
8/8/2012($0.01)($0.07)ViewN/AView Earnings Details
5/9/2012($0.01)($0.05)ViewN/AView Earnings Details
3/9/2012$0.09$0.12ViewN/AView Earnings Details
11/8/2011$0.09$0.10ViewN/AView Earnings Details
8/8/2011$0.08$0.10ViewN/AView Earnings Details
5/3/2011($0.01)$0.05ViewN/AView Earnings Details
3/11/2011$0.04($1.25)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioScrip (NASDAQ:BIOS)
Current Year EPS Consensus Estimate: $-0.29 EPS
Next Year EPS Consensus Estimate: $-0.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.07)($0.07)($0.07)
Q4 20163($0.04)$0.01($0.01)
Q1 20172($0.08)($0.06)($0.07)
Q2 20172($0.06)($0.03)($0.05)
Q3 20172($0.04)($0.03)($0.04)
Q4 20172($0.01)$0.00($0.01)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioScrip (NASDAQ:BIOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioScrip (NASDAQ:BIOS)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 85.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/22/2016Coliseum Capital Management, LDirectorBuy4,200,000$2.00$8,400,000.00View SEC Filing  
6/17/2016David W GoldingDirectorBuy12,500$2.48$31,000.00View SEC Filing  
8/24/2015Coliseum Capital Management, LDirectorBuy789,503$1.88$1,484,265.64View SEC Filing  
8/21/2015Coliseum Capital Management, LDirectorBuy632,907$1.81$1,145,561.67View SEC Filing  
8/18/2015David W GoldingDirectorBuy20,000$1.54$30,800.00View SEC Filing  
3/16/2015Richard M SmithCEOBuy5,000$4.27$21,350.00View SEC Filing  
3/12/2015Yon JordenDirectorBuy5,000$3.47$17,350.00View SEC Filing  
6/16/2014Myron Z HolubiakDirectorSell5,000$7.94$39,700.00View SEC Filing  
5/14/2014Yon JordenDirectorBuy5,000$7.21$36,050.00View SEC Filing  
8/30/2013Daniel ColucciVPSell18,500$12.40$229,400.00View SEC Filing  
8/28/2013David HubersDirectorSell11,200$12.23$136,976.00View SEC Filing  
8/28/2013Patricia BoguszVPSell39,687$11.94$473,862.78View SEC Filing  
8/19/2013Kohlberg Management V, LlcInsiderSell6,895,873$13.00$89,646,349.00View SEC Filing  
7/19/2013Myron Z HolubiakDirectorSell31,200$16.34$509,808.00View SEC Filing  
11/13/2012Stuart A SamuelsDirectorSell11,200$9.66$108,192.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioScrip (NASDAQ:BIOS)
DateHeadline
News IconBioScrip, Inc. (NASDAQ:BIOS) Updated Broker Price Targets - The De Soto Edge (NASDAQ:BIOS)
desotoedge.com - September 29 at 8:32 AM
News IconInterested Penny Stock Investors Keen on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 28 at 3:38 PM
News IconPenny Stock Investors are Growing Curious About BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 27 at 3:51 PM
News IconUnder the Microscope: Zeroing in on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 26 at 3:58 PM
realistinvestor.com logoBioScrip, Inc. (NASDAQ:BIOS) Mean Price Target At $3.916 - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - September 26 at 3:58 PM
News IconKeen Investors Find News on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 24 at 8:05 AM
News IconPenny Stock Investors Keen on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 21 at 3:17 PM
News IconQuarterly Financial Update for BioScrip, Inc. (NASDAQ:BIOS) - Newburgh Press (NASDAQ:BIOS)
newburghpress.com - September 21 at 8:23 AM
News IconPenny Stock Investors Take an Interest in BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 21 at 8:23 AM
News IconConsensus Take: BioScrip, Inc. (NASDAQ:BIOS) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:BIOS)
friscofastball.com - September 21 at 8:23 AM
prnewswire.com logoResearch Reports Coverage on Healthcare Stocks -- Aetna, Anthem, Humana, and BioScrip - PR Newswire (press release) (NASDAQ:BIOS)
www.prnewswire.com - September 21 at 8:23 AM
investornewswire.com logoBioScrip, Inc. (NASDAQ:BIOS) Mean Price Target At $3.916 - Investor Newswire (NASDAQ:BIOS)
www.investornewswire.com - September 17 at 3:47 PM
News IconKeen Investors Seek Information on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 17 at 8:38 AM
nasdaq.com logoBioScrip Buys Home Solutions, Strengthens Infusion Business - Nasdaq (NASDAQ:BIOS)
www.nasdaq.com - September 15 at 8:46 PM
News IconStock Update, a Closer Look at BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 15 at 3:38 PM
News IconBusiness Briefs: BioScrip Closes Acqusition With Home Solutions (NASDAQ:BIOS)
homehealthcarenews.com - September 14 at 9:04 PM
streetinsider.com logoBioScrip (BIOS) Announces Completion of HS Infusion Holdings Acquisition (NASDAQ:BIOS)
www.streetinsider.com - September 14 at 9:04 PM
News IconKeen Investors Narrowing Their Focus on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 14 at 3:52 PM
finance.yahoo.com logoBioScrip Buys Home Solutions, Strengthens Infusion Business (NASDAQ:BIOS)
finance.yahoo.com - September 14 at 3:52 PM
News IconPenny Stock Investors Highly Curious in Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 13 at 5:03 PM
realistinvestor.com logoBioScrip, Inc. (NASDAQ:BIOS) Is Expected To Post EPS Of $-0.02 - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - September 13 at 5:03 PM
News IconBusiness Briefs: BioScrip Closes Acqusition With Home Solutions - Home Health Care News (NASDAQ:BIOS)
homehealthcarenews.com - September 13 at 8:42 AM
biz.yahoo.com logoBIOSCRIP, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Directors or Princip (NASDAQ:BIOS)
biz.yahoo.com - September 13 at 8:42 AM
capitalcube.com logoBioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : September 13, 2016 (NASDAQ:BIOS)
www.capitalcube.com - September 13 at 8:42 AM
News IconGetting a Closer Look at Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 12 at 3:45 PM
realistinvestor.com logoBioScrip, Inc. (NASDAQ:BIOS) Mean Price Target Is $3.916 - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - September 12 at 3:45 PM
streetinsider.com logoBioScrip (BIOS) Announces Completion of HS Infusion Holdings ... - StreetInsider.com (NASDAQ:BIOS)
www.streetinsider.com - September 12 at 8:38 AM
globenewswire.com logoBioScrip Completes Acquisition of Home Solutions Nasdaq:BIOS - GlobeNewswire (press release) (NASDAQ:BIOS)
globenewswire.com - September 10 at 8:34 AM
publicnow.com logoBioScrip Completes Acquisition of Home Solutions (NASDAQ:BIOS)
www.publicnow.com - September 10 at 8:34 AM
News IconMaking News: Targeting shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 9 at 3:45 PM
News IconEarnings Analysis & Update for BioScrip, Inc. (NASDAQ:BIOS)? - Frisco Fastball (NASDAQ:BIOS)
friscofastball.com - September 9 at 3:45 PM
realistinvestor.com logoA Price Target Of $3.916 Is Set By Research Analysts For BioScrip, Inc. (NASDAQ:BIOS) - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - September 9 at 8:40 AM
News IconFocusing the Spotlight on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 8 at 3:45 PM
News IconPlacing BioScrip, Inc. (NASDAQ:BIOS) Shares Under the ... - Post News (NASDAQ:BIOS)
www.kentuckypostnews.com - September 8 at 8:16 AM
News IconNarrowing the Lens on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 7 at 3:51 PM
biz.yahoo.com logoBIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic (NASDAQ:BIOS)
biz.yahoo.com - September 7 at 12:34 PM
bizjournals.com logoNew Denver medical company wants to speed up its big purchase (NASDAQ:BIOS)
www.bizjournals.com - September 6 at 8:40 PM
News IconOTC Investors Supremely Interested in Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 6 at 3:34 PM
News IconHC Stocks Outlines- BioScrip Inc (BIOS), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release) (NASDAQ:BIOS)
sharemarketupdates.com - September 6 at 3:34 PM
finance.yahoo.com logoBioScrip's Deal with Home Solutions Revised, To Close Soon (NASDAQ:BIOS)
finance.yahoo.com - September 6 at 8:39 AM
realistinvestor.com logoPrice Target For BioScrip, Inc. (NASDAQ:BIOS) Set At $3.916 By ... - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - September 4 at 3:42 PM
globenewswire.com logoBioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing - GlobeNewswire (press release) (NASDAQ:BIOS)
globenewswire.com - September 3 at 8:30 AM
finance.yahoo.com logoBioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing (NASDAQ:BIOS)
finance.yahoo.com - September 3 at 8:30 AM
News IconA Second Look at Shares of BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 2 at 3:41 PM
News IconStock in Review: Taking a Closer Look at BioScrip, Inc. (NASDAQ:BIOS) Shares - Post News (NASDAQ:BIOS)
www.kentuckypostnews.com - September 1 at 12:17 PM
News IconUnder the Magnifying Glass: A Closer Look at BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - September 1 at 12:17 PM
capitalcube.com logoETF’s with exposure to BioScrip, Inc. : August 31, 2016 (NASDAQ:BIOS)
www.capitalcube.com - August 31 at 3:48 PM
News IconZeroing Our Focus on BioScrip, Inc. (NASDAQ:BIOS) - Duncan Research (NASDAQ:BIOS)
www.duncanindependent.com - August 30 at 3:48 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NASDAQ:BIOS)
voiceregistrar.com - August 30 at 3:48 PM
capitalcube.com logoBioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : August 30, 2016 (NASDAQ:BIOS)
www.capitalcube.com - August 30 at 8:14 AM

Social

BioScrip (NASDAQ:BIOS) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff